C3 and Huntington disease: Interestingly, despite having similar anti-S levels, SARS-CoV-2-naïve mRV vaccinated HD patients showed a significantly lower deposition of C4b and C3b than controls matched for vaccine type and previous pathogen exposure (Figure 3B,C—comparisons highlighted in purple).